Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV005235934 | SCV005881750 | uncertain significance | not provided | 2024-09-04 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
| Ambry Genetics | RCV005303535 | SCV005958695 | uncertain significance | Inborn genetic diseases | 2025-01-22 | criteria provided, single submitter | clinical testing | The c.2984A>G (p.D995G) alteration is located in exon 29 (coding exon 29) of the VPS13A gene. This alteration results from a A to G substitution at nucleotide position 2984, causing the aspartic acid (D) at amino acid position 995 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |